These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 11103884
1. Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy. Prinssen EP, Koek W, Colpaert FC, Kleven MS. Behav Pharmacol; 2000 Jun; 11(3-4):299-305. PubMed ID: 11103884 [Abstract] [Full Text] [Related]
3. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists. Scott PA, Chou JM, Tang H, Frazer A. J Pharmacol Exp Ther; 1994 Jul 25; 270(1):198-208. PubMed ID: 8035316 [Abstract] [Full Text] [Related]
4. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics. Ninan I, Kulkarni SK. Methods Find Exp Clin Pharmacol; 1999 Nov 25; 21(9):603-8. PubMed ID: 10669905 [Abstract] [Full Text] [Related]
5. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. Tada M, Shirakawa K, Matsuoka N, Mutoh S. Psychopharmacology (Berl); 2004 Oct 25; 176(1):94-100. PubMed ID: 15083255 [Abstract] [Full Text] [Related]
6. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. Kleven MS, Assié MB, Koek W. J Pharmacol Exp Ther; 1997 Aug 25; 282(2):747-59. PubMed ID: 9262338 [Abstract] [Full Text] [Related]
7. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol. Andersen HL, Kilpatrick IC. Br J Pharmacol; 1996 May 25; 118(2):421-7. PubMed ID: 8735647 [Abstract] [Full Text] [Related]
8. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin. Yu H, Liu Y, Malmberg A, Mohell N, Hacksell U, Lewander T. Eur J Pharmacol; 1996 May 15; 303(3):151-62. PubMed ID: 8813561 [Abstract] [Full Text] [Related]
9. In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia. Bardin L, Tarayre JP, Koek W, Colpaert FC. Eur J Pharmacol; 2001 Jun 08; 421(2):109-14. PubMed ID: 11399266 [Abstract] [Full Text] [Related]
10. Serotonin(1A) receptor agonism in the expression of behavioral dopaminergic supersensitivity in subchronic haloperidol treated rats. Batool F, Haleem DJ. Pak J Pharm Sci; 2008 Oct 08; 21(4):411-20. PubMed ID: 18930864 [Abstract] [Full Text] [Related]
11. Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers. Christoffersen CL, Meltzer LT. Neuropsychopharmacology; 1998 May 08; 18(5):399-402. PubMed ID: 9536454 [Abstract] [Full Text] [Related]
12. Modification of behavioral effects of 8-hydroxy-2-(di-n-propylamino)tetralin following chronic ethanol consumption in the rat: evidence for the involvement of 5-HT1A receptors in ethanol dependence. Kleven M, Ybema C, Carilla E, Hamon M, Koek W. Eur J Pharmacol; 1995 Aug 15; 281(3):219-28. PubMed ID: 8521904 [Abstract] [Full Text] [Related]
13. 5-HT1A receptors are not involved in clozapine's lack of cataleptogenic potential. Bartoszyk GD, Roos C, Ziegler H. Neuropharmacology; 1996 Aug 15; 35(11):1645-6. PubMed ID: 9025114 [Abstract] [Full Text] [Related]
14. Circadian rhythm in the hypothermic response to serotonin1A receptor agonist 8-OH-DPAT in rats. Lu JQ, Nagayama H. Chronobiol Int; 1997 May 15; 14(3):267-73. PubMed ID: 9167887 [Abstract] [Full Text] [Related]
15. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Misane I, Johansson C, Ogren SO. Br J Pharmacol; 1998 Oct 15; 125(3):499-509. PubMed ID: 9806333 [Abstract] [Full Text] [Related]
16. Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats. Haleem DJ, Khan NH. Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun 15; 27(4):645-51. PubMed ID: 12787852 [Abstract] [Full Text] [Related]
17. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats. Sugimoto Y, Kimura I, Watanabe Y, Yamada J. Biol Pharm Bull; 2001 Oct 15; 24(10):1191-4. PubMed ID: 11642331 [Abstract] [Full Text] [Related]
18. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain. Casanovas JM, Vilaró MT, Mengod G, Artigas F. J Neurochem; 1999 Jan 15; 72(1):262-72. PubMed ID: 9886078 [Abstract] [Full Text] [Related]
19. 8-OH DPAT can restore the locomotor stimulant effects of cocaine blocked by haloperidol. Carey R, Damianopoulos E, De Palma G. Pharmacol Biochem Behav; 2000 Aug 15; 66(4):863-72. PubMed ID: 10973527 [Abstract] [Full Text] [Related]
20. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors. Clarke RW, Ogilvie J, Houghton AK. Br J Pharmacol; 1997 Oct 15; 122(4):631-8. PubMed ID: 9375958 [Abstract] [Full Text] [Related] Page: [Next] [New Search]